Rothweiler, Ulli published the artcileProbing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules, Product Details of C7H7ClN2S, the publication is Journal of Medicinal Chemistry (2016), 59(21), 9814-9824, database is CAplus and MEDLINE.
DYRK1A has emerged as a potential target for therapies of Alzheimer’s disease using small mols. Based on the observation of selective DYRK1A inhibition by firefly D-luciferin, we have explored static and dynamic structural properties of fragment sized variants of the benzothiazole scaffold with respect to DYRK1A using X-ray crystallog. and NMR techniques. The compounds have excellent ligand efficiencies and show a remarkable diversity of binding modes in dynamic equilibrium Binding geometries are determined in part by interactions often considered “weak”, including “orthogonal multipolar” types represented by e.g. F-CO, sulfur-aromat, and halogen-aromat interactions, together with hydrogen bonds that are modulated by variation of electron withdrawing groups. These studies show how the benzothiazole scaffold is highly promising for the development of therapeutic DYRK1A inhibitors. In addition, the subtleties of the binding interactions, including dynamics, show how full structural studies are required to fully interpret the essential phys. determinants of binding.
Journal of Medicinal Chemistry published new progress about 3696-23-9. 3696-23-9 belongs to chlorides-buliding-blocks, auxiliary class Chloride,Thiourea,Amine,Benzene,Amide, name is 1-(4-Chlorophenyl)thiourea, and the molecular formula is C7H7ClN2S, Product Details of C7H7ClN2S.
Referemce:
https://en.wikipedia.org/wiki/Chloride,
Chlorides – an overview | ScienceDirect Topics